BIOMIMETIC THERAPEUTICS, INC.
DelistedCIK 1138400fmd_1PBQD4JXFDZ7SS6NAFSE419PF4Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2012, 11 periods
Latest annual · FY2012
Millions- Total revenues
- 2
- Operating income
- (30)
- Net income
- (33)
- Free cash flow
- (31)
Latest quarter · Q3 FY2012
Millions- Total revenues
- 1
- Operating income
- (5)
- Net income
- (5)
- Free cash flow
- (5)
BIOMIMETIC THERAPEUTICS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.7 million | $1.5 million | +17.1% | 10-K 2012-03-13 · proof |
| Operating income | -$30.4 million | -$34.6 million | 10-K 2012-03-13 · proof | |
| Net income | -$33.2 million | -$33.9 million | 10-K 2012-03-13 · proof | |
| Cash from operating activities | -$28.7 million | -$27.3 million | 10-K 2012-03-13 · proof | |
| Free cash flow | -$30.6 million | -$27.8 million | 10-K 2012-03-13 · proof |
- What was BIOMIMETIC THERAPEUTICS, INC.'s revenue in fiscal 2012?
- BIOMIMETIC THERAPEUTICS, INC. reported revenue of $1.7 million for fiscal 2012 (the year ended Dec 31, 2011), against $1.5 million the year before (+17.1%). Source: the 10-K filed with the SEC on Mar 13, 2012. SEC
- What was BIOMIMETIC THERAPEUTICS, INC.'s operating income in fiscal 2012?
- BIOMIMETIC THERAPEUTICS, INC. reported operating income of -$30.4 million for fiscal 2012 (the year ended Dec 31, 2011), against -$34.6 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2012. SEC
- What was BIOMIMETIC THERAPEUTICS, INC.'s net income in fiscal 2012?
- BIOMIMETIC THERAPEUTICS, INC. reported net income of -$33.2 million for fiscal 2012 (the year ended Dec 31, 2011), against -$33.9 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2012. SEC
- What was BIOMIMETIC THERAPEUTICS, INC.'s cash from operating activities in fiscal 2012?
- BIOMIMETIC THERAPEUTICS, INC. reported cash from operating activities of -$28.7 million for fiscal 2012 (the year ended Dec 31, 2011), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2012. SEC
- What was BIOMIMETIC THERAPEUTICS, INC.'s free cash flow in fiscal 2012?
- BIOMIMETIC THERAPEUTICS, INC. reported free cash flow of -$30.6 million for fiscal 2012 (the year ended Dec 31, 2011), against -$27.8 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1138400&period_type=annual&limit=5"Information only, not investment advice.